Alford, F.
University of Copenhagen · Odense University Hospital · St Vincent's Hospital Melbourne
4 papers on CoChat
Most cited papers
- Verified
Risk and mechanism of dexamethasone-induced deterioration of glucose tolerance in non-diabetic first-degree relatives of NIDDM patients
Alford, F., Beck-Nielsen, H., Ward, G. M., & Henriksen, J. E. (1997) · Diabetologia
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 115
- Verified
Hormonal effects of norepinephrine on acute glucose disposal in humans: A minimal model analysis
Marangou, A. G., Alford, F. P., Ward, G., Liskaser, F., Aitken, P. M., Weber, K. M., Boston, R. C., & Best, J. D. (1988) · Metabolism
Pancreatic function and diabetesDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 83
- Verified
Glucagon Metabolism in Man. Studies on the Metabolic Clearance Rate and the Plasma Acute Disappearance Time of Glucagon in Normal and Diabetic Subjects
ALFORD, F. P., BLOOM, S. R., & NABARRo, J. D. N. (1976) · The Journal of Clinical Endocrinology & Metabolism
Pancreatic function and diabetesDiabetes Management and Research
Cited by 74
- Verified
Intracellular skeletal muscle glucose metabolism is differentially altered by dexamethasone treatment of normoglycemic relatives of type 2 diabetic patients
Henriksen, J. E., Alford, F., Vaag, A., Handberg, A., & Beck-Nielsen, H. (1999) · Metabolism
Metabolism, Diabetes, and CancerDiabetes, Cardiovascular Risks, and Lipoproteins
Cited by 33
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free